EXTRAPULMONARY SITES OF PSEUDOMONAS-AERUGINOSA IN ADULTS WITH CYSTIC-FIBROSIS

被引:31
|
作者
TAYLOR, RFH
MORGAN, DW
NICHOLSON, PS
MACKAY, IS
HODSON, ME
PITT, TL
机构
[1] CENT PUBL HLTH LAB,DIV HOSP INFECT,LONDON NW9 5HT,ENGLAND
[2] ROYAL BROMPTON HOSP,DEPT EAR NOSE & THROAT,LONDON,ENGLAND
[3] ROYAL NATL THROAT NOSE & EAR HOSP,LONDON WC1X 8DA,ENGLAND
关键词
D O I
10.1136/thx.47.6.426
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Pseudomonas aeruginosa infection is seldom eradicated in patients with cystic fibrosis despite intensive antipseudomonal treatment. Upper airway sites of infection may contribute to perpetuation of lower airways infection. This study was designed to find out which extrapulmonary sites are infected and whether the strains at these sites are identical to those in the lungs. Methods Sputum and upper airway samples from 42 patients were cultured for P aeruginosa and stool samples from 20 patients were also tested. Nineteen isolates from sputum and extra-pulmonary sites from four patients were genotyped with the pCM tox probe. Results P aeruginosa was isolated from the sputum of 36 patients, 34 of whom had infection in the upper airways. Six of the 20 patients tested were positive for P aeruginosa in the stool. The nasopharynx was colonised in 30 patients, the oropharynx in 29, the middle meatus in 13, the external nares in six, and the inferior turbinate in four. Three of four patients tested had the same strain of P aeruginosa (a different one in each individual) in the sputum and the upper airways, and in two of the three the stool isolate was a different strain. Conclusion Most adults with cystic fibrosis and P aeruginosa pulmonary infection have upper airway reservoirs of the organism and strains from these sites are identical to those in the lungs.
引用
收藏
页码:426 / 428
页数:3
相关论文
共 50 条
  • [1] CYSTIC-FIBROSIS AND PSEUDOMONAS-AERUGINOSA
    PIER, GB
    BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (03) : 222 - 222
  • [2] MUCOID PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    HENRY, RL
    DORMAN, DC
    BROWN, J
    MELLIS, CM
    AUSTRALIAN PAEDIATRIC JOURNAL, 1981, 17 (02): : 141 - 142
  • [3] PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS
    HOIBY, N
    JACOBSEN, L
    JORGENSEN, BA
    LYKKEGAARD, E
    WEEKE, B
    ACTA PAEDIATRICA SCANDINAVICA, 1974, 63 (06): : 843 - 848
  • [4] MUCOID PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    HENRY, RL
    DORMAN, DC
    BROWN, J
    MELLIS, C
    AUSTRALIAN PAEDIATRIC JOURNAL, 1982, 18 (01): : 43 - 45
  • [5] AUXOTROPHY OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    TAYLOR, RFH
    HODSON, ME
    PITT, TL
    FEMS MICROBIOLOGY LETTERS, 1992, 92 (03) : 243 - 246
  • [6] MULTIRESISTANT PSEUDOMONAS-AERUGINOSA IN PATIENTS WITH CYSTIC-FIBROSIS
    SHELDON, CD
    HODSON, ME
    THORAX, 1987, 42 (09) : 739 - 739
  • [7] ECOLOGY OF PSEUDOMONAS-AERUGINOSA IN PATIENTS WITH CYSTIC-FIBROSIS
    HORREVORTS, AM
    BORST, J
    PUYK, RJT
    DERIDDER, R
    DZOLJICDANILOVIC, G
    DEGENER, JE
    KERREBIJN, KF
    MICHEL, MF
    JOURNAL OF MEDICAL MICROBIOLOGY, 1990, 31 (02) : 119 - 124
  • [8] SERUM ANTIBODIES TO PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    BRETT, MM
    GHONEIM, ATM
    LITTLEWOOD, JM
    ARCHIVES OF DISEASE IN CHILDHOOD, 1986, 61 (11) : 1114 - 1120
  • [9] PROTEASES OF PSEUDOMONAS-AERUGINOSA IN PATIENTS WITH CYSTIC-FIBROSIS
    DORING, G
    OBERNESSER, HJ
    BOTZENHART, K
    FLEHMIG, B
    HOIBY, N
    HOFMANN, A
    JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (04): : 744 - 750
  • [10] PHENOTYPIC CONVERSION OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    FEGAN, M
    FRANCIS, P
    HAYWARD, AC
    DAVIS, GHG
    FUERST, JA
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (06) : 1143 - 1146